Kallidinogenase - Techpool Bio-PharmaAlternative Names: Kailikang; Urinary Kallidinogenase for Injection; Urinary kallikrein
Latest Information Update: 07 Oct 2015
At a glance
- Originator Techpool Bio-Pharma
- Class Vascular disorder therapies; Vasodilators
- Mechanism of Action Enzyme replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Cerebral infarction